Page 174 - Read Online

sunitinib (case report). World J Surg Oncol 2010;8:36. 2010;41:107‑9.
4. Theodore WH, Gendelman S. Meningeal carcinomatosis. Arch 19. Varyani N, Thukral A, Garg S, Gupta KK, Tandon R, Tripathi K.
Neurol 1981;38:696‑9. Atypical neurofibroma and osteosclerotic metastasis. Case Rep
5. Yap HY, Yap BS, Tashima CK, Distefano A, Blumenschein GR. Oncol Med 2012;2012:301437.
Meningeal carcinomatosis in breast cancer. Cancer 1978;42:283‑6. 20. Scott BJ, van Vugt VA, Rush T, Brown T, Chen CC, Carter BS,
6. Lee JL, Kang YK, Kim TW, Chang HM, Lee GW, Ryu MH, Schwab R, Fanta P, Helsten T, Bazhenova L, Parker B, Pingle S,
Kim E, Oh SJ, Lee JH, Kim SB, Kim SW, Suh C, Lee KH, Lee JS, Saria MG, Brown BD, Piccioni DE, Kesari S. Concurrent intrathecal
Kim WK, Kim SH. Leptomeningeal carcinomatosis in gastric cancer. methotrexate and liposomal cytarabine for leptomeningeal
J Neurooncol 2004;66:167‑74. metastasis from solid tumors: a retrospective cohort study.
7. Nakagawa H, Murasawa A, Kubo S, Nakajima S, Nakajima Y, J Neurooncol 2014;119:361‑8.
Izumoto S, Hayakawa T. Diagnosis and treatment of patients with 21. Patel A, Ayto R, MacDonald DH. Posterior reversible encephalopathy
meningeal carcinomatosis. J Neurooncol 1992;13:81‑9. after intrathecal methotrexate therapy in diffuse large B‑cell
8. Boogerd W, Vroom TM, van Heerde P, Brutel De La lymphoma. Br J Haematol 2013;161:607.
Riviere G, Peterse JL, van der Sande JJ. CSF cytology versus 22. Back EH. Death after intrathecal methotrexate. Lancet 1969;2:1005.
immunocytochemistry in meningeal carcinomatosis. J Neurol 23. Herrlinger U, Wiendl H, Renninger M, Forschler H, Dichgans J,
Neurosurg Psychiatry 1988;51:142‑5. Weller M. Vascular endothelial growth factor (VEGF) in
9. Beauchesne P. Intrathecal chemotherapy for treatment of leptomeningeal metastasis: diagnostic and prognostic value. Br J
leptomeningeal dissemination of metastatic tumours. Lancet Oncol Cancer 2004;91:219‑24.
2010;11:871‑9. 24. Pace A, Fabi A. Chemotherapy in neoplastic meningitis. Crit Rev
10. Kaplan JG, DeSouza TG, Farkash A, Shafran B, Pack D, Rehman F, Oncol Hematol 2006;60:194‑200.
Fuks J, Portenoy R. Leptomeningeal metastases: comparison of 25. Mason WP, Yeh SD, DeAngelis LM. 111Indium‑diethylenetriamine
clinical features and laboratory data of solid tumors, lymphomas pentaacetic acid cerebrospinal fluid flow studies predict distribution
and leukemias. J Neurooncol 1990;9:225‑9. of intrathecally administered chemotherapy and outcome in patients
11. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment with leptomeningeal metastases. Neurology 1998;50:438‑44.
of leptomeningeal metastases from solid tumors: experience with 26. Tay AS, Liu EH, Lee TL, Miyazaki S, Nishimura W, Minami T,
90 patients. Cancer 1982;49:759‑72. Chan YH, Low CM, Tachibana S. Cerebrospinal fluid of postherpetic
12. Lampkin BC, Higgins GR, Hammond D. Absence of neurotoxicity neuralgia patients induced interleukin‑6 release in human glial
following massive intrathecal administration of methotrexate. Case cell‑line T98G. Neurochem Int 2013;63:517‑21.
report. Cancer 1967;20:1780‑1. 27. Valentin A, Troppan K, Pfeilstocker M, Nosslinger T, Linkesch W,
13. Tomita N, Takasaki H, Ishiyama Y, Kishimoto K, Ishibashi D, Neumeister P. Safety and tolerability of intrathecal liposomal
Koyama S, Ishii Y, Takahashi H, Numata A, Watanabe R, cytarabine as central nervous system prophylaxis in patients
Tachibana T, Ohshima R, Hagihara M, Hashimoto C, Takemura S, with acute lymphoblastic leukemia. Leuk Lymphoma
Taguchi J, Fujimaki K, Sakai R, Motomura S, Ishigatsubo Y. 2014;55:1739‑42.
Intrathecal methotrexate prophylaxis and central nervous system 28. Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L,
relapse in patients with diffuse large B‑cell lymphoma following Swinnen LJ, Maria B, Lafollette S, Schumann GB, Cole BF,
rituximab plus cyclophosphamide, doxorubicin, vincristine and Howell SB. A randomized controlled trial comparing intrathecal
prednisone. Leuk Lymphoma 2015;56:725‑9. sustained‑release cytarabine (DepoCyt) to intrathecal methotrexate
14. Lee E, Keam B, Kim DW, Kim TM, Lee SH, Chung DH, Heo DS. in patients with neoplastic meningitis from solid tumors. Clin Cancer
Erlotinib versus gefitinib for control of leptomeningeal carcinomatosis Res 1999;5:3394‑402.
in non‑small‑cell lung cancer. J Thorac Oncol 2013;8:1069‑74. 29. Oechsle K, Lange‑Brock V, Kruell A, Bokemeyer C, de Wit M.
15. Jo JC, Kang MJ, Kim JE, Ahn JH, Jung KH, Gong G, Kim HH, Prognostic factors and treatment options in patients with
Ahn SD, Kim SS, Son BH, Ahn SH, Kim SB. Clinical features leptomeningeal metastases of different primary tumors: a retrospective
and outcome of leptomeningeal metastasis in patients with breast analysis. J Cancer Res Clin Oncol 2010;136:1729‑35.
cancer: a single center experience. Cancer Chemother Pharmacol 30. Le Rhun E, Taillibert S, Chamberlain MC. Carcinomatous meningitis:
2013;72:201‑7. leptomeningeal metastases in solid tumors. Surg Neurol Int
16. Marjanovic S, Mijuskovic Z, Stamatovic D, Madjaru L, Ralic T, 2013;4:S265‑88.
Trimcev J, Stojanovic J, Radovic V 2nd. Multiple myeloma invasion
of the central nervous system. Vojnosanit Pregl 2012;69:209‑13.
17. Tomita H, Yasui H, Boku N, Nakasu Y, Mitsuya K, Onozawa Y,
Fukutomi A, Yamazaki K, Machida N, Taku K, Todaka A, Cite this article as: Lv WJ, He JY, Zou YL, Liu YJ, Zhang QQ, Liu X, Bu H.
Intrathecal dexamethasone and methotrexate treatment of neoplastic meningitis
Taniguchi H, Tsushima T. Leptomeningeal carcinomatosis associated from solid tumors. Neuroimmunol Neuroinflammation 2015;2(3):162-6.
with gastric cancer. Int J Clin Oncol 2012;17:361‑6.
18. Minchom A, Chan S, Melia W, Shah R. An unusual case of pancreatic Source of Support: Nil. Conflict of Interest: No.
cancer with leptomeningeal infiltration. J Gastrointest Cancer Received: 21-11-2014; Accepted: 08-06-2015

166 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 PB